Skip to main content
. 2017 Jan 11;12(1):e0167640. doi: 10.1371/journal.pone.0167640

Table 1. Clinical characteristics.

  Healthy control HIV+/IR HIV+/INR P value (IR vs INR)
Total no. of subjects 12 13 11
No. of male/female 3 ⁄ 9 11 ⁄ 2 6 ⁄ 5 0.08
Age (yr) 44 (34–58) 43 (31–49) 47 (36–56) 0.21
Plasma HIV RNA Not detectable Not detectable
CD4+ T cell counts 782 (513–944) 733 (658–777) 322 (225–349) < 0.0001
Years of ART 15 (13.8–15.0) 14 (11.0–16.0) 0.46
%CD38+HLA-DR+CD4+ 1.17 (1.0–2.2) 1.96 (1.2–3.2) 0.09
Nadir CD4+ T cell counts   320 (215–507) 170 (92–195) 0.001

CD4+ T cell counts (cells/μl).

Plasma HIV RNA (copies/ml).

Data are medians (interquartile ranges).